Magnetic Resonance Elastography Predicts Advanced Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Study

Retrospective studies have shown that two‐dimensional magnetic resonance elastography (2D‐MRE), a novel MR method for assessment of liver stiffness, correlates with advanced fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Prospective data on diagnostic accuracy of 2D‐MRE in the detection of advanced fibrosis in NAFLD are needed. The aim of this study is to prospectively assess the diagnostic accuracy of 2D‐MRE, a noninvasive imaging biomarker, in predicting advanced fibrosis (stage 3 or 4) in well‐characterized patients with biopsy‐proven NAFLD. This is a cross‐sectional analysis of a prospective study including 117 consecutive patients (56% women) with biopsy‐proven NAFLD who underwent a standardized research visit: history, exam, liver biopsy assessment (using the nonalcoholic steatohepatitis Clinical Research Network histological scoring system), and 2D‐MRE from 2011 to 2013. The radiologist and pathologist were blinded to clinical and pathology/imaging data, respectively. Receiver operating characteristics (ROCs) were examined to assess the diagnostic test performance of 2D‐MRE in predicting advanced fibrosis. The mean (± standard deviation) of age and body mass index was 50.1 (± 13.4) years and 32.4 (± 5.0) kg/m2, respectively. The median time interval between biopsy and 2D‐MRE was 45 days (interquartile range: 50 days). The number of patients with fibrosis stages 0, 1, 2, 3, and 4 was 43, 39, 13, 12, and 10, respectively. The area under the ROC curve for 2D‐MRE discriminating advanced fibrosis (stage 3‐4) from stage 0‐2 fibrosis was 0.924 (P < 0.0001). A threshold of >3.63 kPa had a sensitivity of 0.86 (95% confidence interval [CI]: 0.65‐0.97), specificity of 0.91 (95% CI: 0.83‐0.96), positive predictive value of 0.68 (95% CI: 0.48‐0.84), and negative predictive value of 0.97 (95% CI: 0.91‐0.99). Conclusions: MRE is accurate in predicting advanced fibrosis and may be utilized for noninvasive diagnosis of advanced fibrosis in patients with NAFLD. (Hepatology 2014;60:1919–1927)

[1]  S. Reeder,et al.  Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.

[2]  Ned C. Rouze,et al.  Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. , 2011, Journal of hepatology.

[3]  Z. Younossi,et al.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.

[4]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[5]  Mark Bydder,et al.  Robustness of fat quantification using chemical shift imaging. , 2012, Magnetic resonance imaging.

[6]  J. George,et al.  Fatty liver disease: NASH and related disorders , 2004 .

[7]  S. Horgan,et al.  Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.

[8]  A. Gamst,et al.  Assessment of liver fat quantification in the presence of iron. , 2010, Magnetic resonance imaging.

[9]  A. McCullough.  The Epidemiology and Risk Factors of NASH , 2007 .

[10]  C. Sirlin,et al.  Relaxation effects in the quantification of fat using gradient echo imaging. , 2008, Magnetic resonance imaging.

[11]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[12]  S. Reeder,et al.  Quantification of hepatic steatosis with MRI: The effects of accurate fat spectral modeling , 2009, Journal of magnetic resonance imaging : JMRI.

[13]  S. Reeder,et al.  Fat quantification with IDEAL gradient echo imaging: Correction of bias from T1 and noise , 2007, Magnetic resonance in medicine.

[14]  Miriam B. Vos,et al.  Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. , 2013, The Journal of pediatrics.

[15]  R. Ehman,et al.  Magnetic resonance elastography of liver: Technique, analysis, and clinical applications , 2013, Journal of magnetic resonance imaging : JMRI.

[16]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[17]  A. Gamst,et al.  Reproducibility of MRI‐determined proton density fat fraction across two different MR scanner platforms , 2011, Journal of magnetic resonance imaging : JMRI.

[18]  S. Caldwell,et al.  Epidemiology and natural history of non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.

[19]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[20]  K. Cusi,et al.  The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.

[21]  A. Sanyal,et al.  Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  Robert A Fisher,et al.  Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.

[23]  C. Sirlin,et al.  In vivo characterization of the liver fat 1H MR spectrum , 2011, NMR in biomedicine.

[24]  R. Loomba,et al.  Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease , 2012, Alimentary pharmacology & therapeutics.

[25]  A. Gamst,et al.  Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. , 2009, Radiology.

[26]  Laurent Castera,et al.  Noninvasive evaluation of NAFLD , 2013, Nature Reviews Gastroenterology &Hepatology.

[27]  A. Gamst,et al.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.

[28]  M. Lupsor,et al.  Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta‐analysis , 2012, Journal of viral hepatitis.

[29]  A. Berzigotti,et al.  Update on ultrasound imaging of liver fibrosis. , 2013, Journal of hepatology.

[30]  D. Kleiner,et al.  Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. , 2004, Human pathology.

[31]  Rohit Loomba,et al.  Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials , 2013, Hepatology.

[32]  Enzo Bonora,et al.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[33]  R. Loomba,et al.  Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers , 2012, Clinical liver disease.

[34]  K. Cusi,et al.  Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. , 2014, Journal of hepatology.

[35]  Rohit Kohli,et al.  Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease. , 2014, The Journal of pediatrics.

[36]  M. Abraham,et al.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis , 2012, Hepatology.

[37]  S. Sanderson,et al.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. , 2005, Journal of hepatology.

[38]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[39]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[40]  A. Manduca,et al.  Assessment of hepatic fibrosis with magnetic resonance elastography. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[42]  Richard L Ehman,et al.  Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. , 2013, Radiology.

[43]  R. Ehman,et al.  Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. , 2011, Radiology.

[44]  S. Reeder,et al.  Proton density fat‐fraction: A standardized mr‐based biomarker of tissue fat concentration , 2012, Journal of magnetic resonance imaging : JMRI.

[45]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[46]  J. Schwimmer,et al.  Hepatic, Cardiovascular, and Endocrine Outcomes of the Histological Subphenotypes of Nonalcoholic Fatty Liver Disease , 2008, Seminars in liver disease.

[47]  D. Brenner,et al.  Effect of Colesevelam on Liver Fat Quantified by Magnetic Resonance in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial , 2012, Hepatology.

[48]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[49]  A. Pollett,et al.  Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients , 2012, Hepatology.

[50]  M McCarthy,et al.  Hepatology , 1999, Rapid Medicine.

[51]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[52]  A. Gamst,et al.  Spatial distribution of MRI‐determined hepatic proton density fat fraction in adults with nonalcoholic fatty liver disease , 2014, Journal of magnetic resonance imaging : JMRI.

[53]  G. Chejfec,et al.  Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? , 2008, Archives of pathology & laboratory medicine.

[54]  Don C. Rockey,et al.  AASLD position paper: Liver biopsy , 2008 .

[55]  D. Brenner,et al.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non‐alcoholic fatty liver disease – MRI accurately quantifies hepatic steatosis in NAFLD , 2012, Alimentary pharmacology & therapeutics.

[56]  R. Ehman,et al.  Role of magnetic resonance elastography in compensated and decompensated liver disease. , 2014, Journal of hepatology.

[57]  V. Wong,et al.  Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease , 2012, The American Journal of Gastroenterology.